Prolonging survival of platelets using CMP-sialic acid,UDP-galactose or both
US8221745B2 · kind B2 · utility
2Cited by
13References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 14, 2008 |
| Grant date | Jul 17, 2012 |
| Priority date | — |
| Expiry date | Jan 4, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N5/0644
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides modified platelets having a reduced platelet clearance and methods for reducing platelet clearance. Also provided are compositions for the preservation of platelets. The invention also provides methods for making a pharmaceutical composition containing the modified platelets and for administering the pharmaceutical composition to a mammal to mediate hemostasis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.